相关实验视频
Updated: May 5, 2026

12:09
Studying Food Reward and Motivation in Humans
Published on: March 19, 2014
23.0K
在库辛病中使用帕西里欧提德-LAR的现实世界经验:单中心12个月观察性研究
Lukasz Dzialach1, Wioleta Respondek2, Przemyslaw Witek1
1Department of Internal Medicine, Endocrinology and Diabetes, Medical University of Warsaw, 03-242 Warsaw, Poland.
Journal of clinical medicine
|April 26, 2025
概括
帕西雷胺-LAR在实际使用中有效控制库辛病 (CD),降低皮质醇水平并改善血压. 高血糖是最常见的可管理的副作用.
科学领域:
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 库辛病 (CD) 需要有效的治疗选择.
- 对CD的长效沙胺 (LAR) 的现实世界数据有限.
- 帕西里欧提德-LAR是一种用于CD的新型治疗剂.
研究的目的:
- 在现实世界CD患者队列中评估12个月的沙雷胺-LAR的疗效和安全性.
- 评估对疾病控制,葡萄糖代谢和脂质概况的影响.
- 为了记录与表达胺-LAR治疗相关的不良事件.
主要方法:
- 从单个垂体中心前性收集数据的回顾性分析.
- 包括用化物-LAR治疗的持续性或复发性CD患者.
- 在12个月内评估尿液自由皮质醇 (mUFC),唾液皮质醇,血压,葡萄糖和HbA1c的平均值.
主要成果:
- 观察到mUFC持续下降,在前3个月内显著减少.
- 血压控制的改善,特别是在6个月内静脉压下降.
- 高血糖是最常见的不良反应,在最后一次随访时HbA1c显著增加.
结论:
- 在现实环境中,Pasireotide-LAR证明了其作为选择性CD患者的替代治疗方法的有效性.
- 这种治疗通常是安全的,并且耐受性很好.
- 高血糖是常见的,但可以管理的不良事件,需要监测.
相关概念视频
Cushing Syndrome I: Introduction
46
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the...
46
Cushing Syndrome II: Pathophysiology
56
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features...
56

